420 related articles for article (PubMed ID: 25380929)
21. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
Miyagawa Y; Tominaga Y; Toda N; Takemura N
Vet J; 2013 Aug; 197(2):445-50. PubMed ID: 23570775
[TBL] [Abstract][Full Text] [Related]
22. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[TBL] [Abstract][Full Text] [Related]
23. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.
Konta T; Ikeda A; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Yoshida H; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
Am J Hypertens; 2012 Mar; 25(3):342-7. PubMed ID: 22089103
[TBL] [Abstract][Full Text] [Related]
25. Influence of Blood Pressure and Calcineurin Inhibitors on Kidney Function After Heart or Liver Transplantation.
Morath C; Opelz G; Döhler B; Zeier M; Süsal C
Transplantation; 2018 May; 102(5):845-852. PubMed ID: 29215461
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Chronic Renal Insufficiency Following Cardiac Transplantation.
Lachance K; White M; de Denus S
Ann Transplant; 2015 Sep; 20():576-87. PubMed ID: 26417876
[TBL] [Abstract][Full Text] [Related]
28. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
[TBL] [Abstract][Full Text] [Related]
29. Serum midkine is related to NYHA class and cystatin C in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Nov; 42(9):3704-7. PubMed ID: 21094842
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
Zawiasa A; Nowicki M
Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
[TBL] [Abstract][Full Text] [Related]
31. Predictors of renal function following lung or heart-lung transplantation.
Ishani A; Erturk S; Hertz MI; Matas AJ; Savik K; Rosenberg ME
Kidney Int; 2002 Jun; 61(6):2228-34. PubMed ID: 12028464
[TBL] [Abstract][Full Text] [Related]
32. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
[TBL] [Abstract][Full Text] [Related]
33. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients.
Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ
J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913
[TBL] [Abstract][Full Text] [Related]
34. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
35. N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients.
Wyskida K; Ficek J; Ficek R; Adamska D; Jędrzejowska P; Wajda J; Klein D; Witkowicz J; Rotkegel S; Spiechowicz-Zatoń U; Kocemba-Dyczek J; Ciepał J; Więcek A; Olszanecka-Glinianowicz M; Chudek J
Kidney Blood Press Res; 2017; 42(6):1013-1022. PubMed ID: 29190613
[TBL] [Abstract][Full Text] [Related]
36. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
37. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
[TBL] [Abstract][Full Text] [Related]
38. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
39. Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial.
Rahn KH; Barenbrock M; Fritschka E; Heinecke A; Lippert J; Schroeder K; Hauser I; Wagner K; Neumayer HH
Lancet; 1999 Oct; 354(9188):1415-20. PubMed ID: 10543667
[TBL] [Abstract][Full Text] [Related]
40. Blood Pressure Control During Chronic Kidney Disease Progression.
Lee S; Oh HJ; Lee EK; Lee O; Ha E; Kim SJ; Kang DH; Choi KB; Ryu DR
Am J Hypertens; 2017 Jun; 30(6):610-616. PubMed ID: 28338771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
